The addition of anti-angiogenic tyrosine kinase inhibitors to chemotherapy for patients with advanced non-small-cell lung cancers: a meta-analysis of randomized trials Li, Bob T., Barnes, Tristan A., Chan, David L., Naidoo, Jarushka, Lee, Adrian, Khasraw, Mustafa, Marx, Gavin M., Kris, Mark G., Clarke, Stephen J., Drilon, Alexander, Rudin, Charles M. and Pavlakis, Nick 2016, The addition of anti-angiogenic tyrosine kinase inhibitors to chemotherapy for patients with advanced non-small-cell lung cancers: a meta-analysis of randomized trials, Lung Cancer, vol. 102, pp. 21-27, doi: 10.1016/j.lungcan.2016.10.004. Attached Files Name Description MIMEType Size Downloads Title The addition of anti-angiogenic tyrosine kinase inhibitors to chemotherapy for patients with advanced non-small-cell lung cancers: a meta-analysis of randomized trials Author(s) Li, Bob T. Barnes, Tristan A. Chan, David L. Naidoo, Jarushka Lee, Adrian Khasraw, Mustafa orcid.org/0000-0003-3249-9849 Marx, Gavin M. Kris, Mark G. Clarke, Stephen J. Drilon, Alexander Rudin, Charles M. Pavlakis, Nick Journal name Lung Cancer Volume number 102 Start page 21 End page 27 Total pages 7 Publisher Elsevier Ireland Place of publication Shannon, Ireland Publication date 2016-12 ISSN 0169-5002 1872-8332 Keyword(s) Angiogenesis lung cancer meta-analysis tyrosine kinase inhibitors Angiogenesis Inhibitors Antineoplastic Agents Antineoplastic Combined Chemotherapy Protocols Carcinoma, Non-Small-Cell Lung Combined Modality Therapy Disease-Free Survival Human body Lung Neoplasms Protein Kinase Inhibitors Protein-Tyrosine Kinases Randomized Controlled Trials as Topic Receptors, Vascular Endothelial Growth Factor Vascular Endothelial Growth Factor A Science & Technology Life Sciences & Biomedicine Oncology Respiratory System MOTESANIB PLUS CARBOPLATIN/PACLITAXEL PHASE-II DOUBLE-BLIND 1ST-LINE TREATMENT TUMOR ANGIOGENESIS PLACEBO VANDETANIB DOCETAXEL PACLITAXEL BEVACIZUMAB Language eng DOI 10.1016/j.lungcan.2016.10.004 Field of Research 1112 Oncology And Carcinogenesis 1103 Clinical Sciences HERDC Research category C1.1 Refereed article in a scholarly journal ERA Research output type C Journal article Copyright notice ©2016, Elsevier Ireland Ltd. Persistent URL http://hdl.handle.net/10536/DRO/DU:30109285 Document type: Journal Article Collections: Faculty of Health School of Medicine Molecular and Medical Research Related Links Link Description Connect to published version Go to link with your DU access privileges   Connect to Elements publication management system Go to link with your DU access privileges     Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved. Versions Version Filter Type Tue, 12 Jun 2018, 09:34:27 EST Wed, 13 Jun 2018, 05:00:58 EST Wed, 13 Jun 2018, 06:04:19 EST Wed, 13 Jun 2018, 15:51:06 EST Wed, 13 Jun 2018, 15:54:59 EST Filtered Full Citation counts:   Cited 0 times in TR Web of Science Cited 2 times in Scopus Search Google Scholar Access Statistics: 5 Abstract Views, 1 File Downloads  -  Detailed Statistics Created: Tue, 12 Jun 2018, 09:34:27 EST

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.